Cypress Capital Group Idexx Laboratories Inc Transaction History

Cypress Capital Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$325.8 - $407.78 $1,303 - $1,631	-4 Reduced 0.38%	1,044 $340,000
Q2 2022 Jul 26, 2022	SELL	$327.37 - $553.44 $188,565 - $318,781	-576 Reduced 35.47%	1,048 $368,000
Q1 2022 May 16, 2022	SELL	$466.52 - $631.01 $230,927 - $312,349	-495 Reduced 23.36%	1,624 $889,000
Q4 2021 Feb 15, 2022	SELL	$586.54 - $666.48 $5,865 - $6,664	-10 Reduced 0.47%	2,119 $1.4 Million
Q3 2021 Oct 12, 2021	BUY	$621.9 - $705.76 $233,212 - $264,660	375 Added 21.38%	2,129 $1.32 Million
Q2 2021 Jul 13, 2021	SELL	$486.36 - $637.08 $26,749 - $35,039	-55 Reduced 3.04%	1,754 $1.11 Million
Q1 2021 Apr 14, 2021	BUY	$465.18 - $551.79 $7,442 - $8,828	16 Added 0.89%	1,809 $885,000
Q4 2020 Jan 12, 2021	BUY	$383.85 - $499.87 $170,429 - $221,942	444 Added 32.91%	1,793 $896,000
Q3 2020 Oct 08, 2020	BUY	$334.54 - $406.31 $451,294 - $548,112	1,349 New	1,349 $531,000

1,208

72M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $36B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

Stay updated on Cypress Capital Group with notifications on news.